Absci rises on $20 million investment from AMD

** Shares of AI biologics firm Absci Corp  ABSI.O  rise
30.6% to $4.01 premarket 
    ** Co announces a strategic collaboration with Advanced
Micro Devices  AMD.O , where the chipmaker will invest $20 mln
in co to power AI drug discovery 
    ** The investment is structured as a private investment in
public equity or PIPE financing
    ** The partnership will provide AI solutions and also help
reduce infrastructure costs for ABSI
     ** ABSI will deploy AMD's AI chips to help in drug
discovery which "will enable us to further the development of
next-generation antibody therapeutics"- ABSI 
    ** Absci previously struck a deal worth up to $247 mln with 
drugmaker AstraZeneca  AZN.L  to design an antibody to fight
cancer
    ** Up to last close, ABSI had fallen 8.6% in the past 12
months 

 (Reporting by Sneha S K)
 ((Sneha.SK@thomsonreuters.com;))

Recent news on AbSci

See all news